Cognitive-behavior therapy with eating disorders: The role of medications in treatment

Journal of Cognitive Psychotherapy

Volumn 21, Issue 1, 2007, Pages 16-27

  Bowers, Wayne A ^a,b   Andersen, Arnold E ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Cognitive therapy; Combined treatment; Eating disorders; Medications

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CYPROHEPTADINE; FLUOXETINE; HALOPERIDOL; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANOREXIA NERVOSA; ANXIETY; BEHAVIOR THERAPY; BINGE EATING DISORDER; BULIMIA; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; EATING DISORDER; HUMAN; PSYCHOTHERAPIST; REMISSION; REVIEW; SIDE EFFECT; WEIGHT GAIN;

EID: 33947517744     PISSN: 08898391     EISSN: None     Source Type: Journal    
DOI: 10.1891/088983907780493359     Document Type: Review

References (88)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. American Psychiatric Association. (2000). Practice guidelines for treatment of patients with eating disorders (revised). American Journal of Psychiatry, 57(Suppl. 1), 1-39.
3. Appolinarion, J. C., & McElroy, S. L. (2004). Pharmacological approaches in the treatment of binge eating disorder. Current Drug Targets, 5, 301-307.
4. Agras, W. S., Rossiter, E. M., Arnow, B., Telch, Raeburn, C. F., Bruce, B., et al. (1994). One year follow up of psychosocial pharmacologic treatments of bulimia nervosa. Journal of Clinical Psychiatry, 52, 29-33.
5. Agras, W. S., Walsh, T., Fairburn, C. G., Wilson, G. T., & Kraemer, H. C. (2000). A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Archives of General Psychiatry, 57, 459-466.
6. Attia, E., Haiman, C., Walsh, B. T., & Plater, S. R. (1998). Does fluoxetine augment the inpatient treatment of anorexia nervosa? American Journal of Psychiatry, 155, 548-551.
7. Attia, E., Mayer, L., & Killory, E. (2001). Medication response in the treatment of patients with anorexia nervosa. Journal of Psychiatric Practice, 7, 157-162.
8. Bacaltchuk, J., Hay, P., & Mari, J. (2000). Antidepressant versus placebo for the treatment of bulimia nervosa: A systematic review. Australian and New Zealand Journal of Psychiatry, 34, 310-317.
9. Beck, A. T., Rush, A. G., Shaw, B. R, & Emery, G. (1979). Cognitive therapy of depression. New York: Guildord.
10. Biederman, J., Herzog, D. B., Rivinus, T. M., Harper, G. P., Ferber, R. A., Rosenbaum, J. F., et al. (1985). Amitriptyline in the treatment of anorexia nervosa. Journal of Clinical Psychopharmacology, 5, 10-16.
11. Boachie, A. Goldfield, G. S., & Spettigue, W. (2003). Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports. International Journal of Eating Disorders, 33, 98-103.
12. Bowers, W. A. (1993). Cognitive therapy for eating disorders. In J. H. Wright, M. E. Thase, A. T. Beck, & J. W. Ludgate (Eds.), Cognitive therapy with impatients: Developing a cognitive milieu (pp. 337-356). New York: Guilford.
13. Bowers, W. A. (2001). Basic principles for applying cognitive-behavioral therapy to anorexia nervosa. Psychiatric Clinics of North America, 24, 293-304.
14. Bowers, W. A., & Andersen, A. E. (1994). Inpatient treatment of anorexia nervosa: Review and recommendations. Harvard Review of Psychiatry, 2, 193-203.
15. Bowers, W. A., Andersen, A. E., & Evans, K. K. (2004). Management for eating disorders: Inpatient and partial hospital programs. In T. B Brewerton (Ed.), Clinical handbook of eating disorders (pp. 349-376). New York: Marcel Deeker.
16. Bowers, W. A., & Ansher, L. (2000). Cognitions in anorexia nervosa: Changes at discharge from a cognitive therapy milieu inpatient treatment program. International Journal of Cognitive Therapy, 14, 393-401.
17. Brewerton, T. D. (2004). Clinical handbook of eating disorders. New York: Marcel Dekker.
18. Cassano, G. B., Miniati, M., Pini, S., Rotondo, A., Banti, S., Borri, C., et al. (2003). Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: A preliminary study. International Journal of Eating Disorders, 33, 172-177.
19. Channon, S., de Silva, P., Hemsley, D., & Perkins, R. (1989). A controlled trial of cognitive- behavioural and behavioural treatment of anorexia nervosa. Behavior Research and Therapy, 27, 529-535.
20. Cooper, M. C. (2003). The psychology of bulimia nervosa: A cognitive perspective. Oxford, UK: Oxford University Press.
21. Corinna, J., Dahme, B., & Dittman, R. (2002). Cognitive-behavioural, fluoxetine and combined treatement for bulimia nervosa: Short-and long-term results. European Eating Disorders Review, 3, 179-198.
22. Crow, S., & Brown, E. (2003). Investigational drugs for eating disorders. Expert Opinion on Investigational Drugs, 12, 491-499.
23. Dalla Grave, R., Ricca, V., & Todesco (2001). The stepped-care approach in anorexia nervosa and bulimia nervosa: Progress and problems. Eating and Weight Disorders, 6, 81-89.
24. Dally, P. J., & Sargant, W. (1960). A new treatment of anorexia nervosa. British Medical Journal, 1, 1770-1773.
25. Dally, P. J., & Sargant, W. (1966). Treatment and outcome of anorexia nervosa. British Medical Journal, 2, 793-795.
26. Devlin, M. J., Goldfein, J. A., Carino, J. S., & Wölk, S. L. (2000). Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy. International Journal of Eating Disorders, 28, 325-332.
27. DeZwaan, M., Roerig, J. L., & Mitchell, J. E. (2004.) Pharmacological treatment of anorexia, bulimia nervosa, and binge eating disorder. In J. K. Thompson (Ed.), Handbook of eating disorders and obesity (pp. 186-217). Hoboken, NJ: Wiley and Sons.
28. Ercan, E. S., Copkunol, H., Cykoethlu, S., & Varan, A. (2003). Olanzapine treatment of an adolescent girl with anorexia nervosa. Human Psychopharmacology, 18, 401-413.
29. Fechter, M. M., Leibl, K., Reif, W., Brunner, E., Schmidt-Auberger, S., & Engel, R. R. (1991). Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacothcrapy, 24, 1-7.
30. Ferguson, J. M. (1987). Treatment of an anorexia nervosa patient with fluoxetine. American Journal of Psychiatry, 144, 1239.
31. Fernandez-Aranda, F., Bel, M., Jimenez, S., Vinuales, M., Turon, & Vallejo, J. (1998). Outpatient group therapy for anorexia nervosa: A preliminary study. Eating and Weight Disorders, 3, 10-6.
32. Garner, D. M., Vitousek, K. M., & Pike, K. M. (1997). Cognitive-behavioral therapy for anorexia nervosa. In D. M. Garner & P. E. Garfinkel (Eds.), Handbook of treatment eating disorders (2nd éd., pp. 94-144). New York: Guilford.
33. Goldbloom, D. A., Olmsted, M., Davis, R., Clews, J., Heinmaa, W., Rockert, W., et al. (1997). Randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa. Behavior Therapy and Research, 35, 803-811.
34. Gorin, A., Le Grange, D., & Stone, A. A. (2003). Effectiveness of spouse involvement in cognitive-behavioral group therapy for binge eating disorder. International Journal of Eating Disorders, 33, 421-433.
35. Grilo, C. M., Masheb, R. M., & Wilson, G. T. (2001). Subtyping binge eating disorder. Journal of Consulting and Clinical Psychology, 69, 1066-1072.
36. Gwirtsman, H. E., Guze, B. H., Yager, J., & Gainsley, B. (1991). Fiuoxetine treatment of anorexia nervosa: An open clinical trial. Journal of Clinical Psychiatry, 51, 378-382.
37. Halmi, K. A., Eckert, E., La Du, T. J., & Cohen, J. (1986). Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Archives of General Psychiatry, 43, 177-186.
38. Hudson, J., McElroy, S. L., Raymond, N., et al. (1998). Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial. American Journal of Psychiatry, 155, 1756-1762.
39. Hudson, J. I., Pope, H. G., Jonas, J. M., & Yurgelun-Todd, D. (1985). Treatment of anorexia nervosa with antidepressants. Journal of Clinical Psychopharmacology, 5, 17-23.
40. Kaye, W., Nagata, T., Weltzin, T., Hsu, L. K. G., Sokol, M. S., McConaha, C., et al. (2001). Double-blind placebo-controlled administration of fluoxetine in restricting and restricting-purging-type anorexia nervosa. Biological Psychiatry, 49, 644-652.
41. Kaye, W. H., Weltzin, T. E., Hsu, L. K. G., & Bulik, C. M. (1991). An open trial of fluoxetine in patients with anorexia nervosa. Journal of Clinical Psychiatry, 52, 464-471.
42. Keel, P. K., Mitchell, J. E., Davis, T. L., & Crow, S. J. (2002). Long-term impact of treatment in women diagnosed with bulimia nervosa. International Journal of Eating Disorders, 31, 151-158.
43. Kennedy, S. H., Piran, N., & Garfinkel, P. E. (1985). Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: A preliminary trial of isocarboxazid. Journal of Clinical Psychopharmacology, 5, 279-285.
44. Lacey, J. H., & Crisp, A. H. (1980). Hunger, food intake and weight: The impact of clomipramine on a refeeding anorexia nervosa population. Postgraduate Medical Journal, 56 (Suppl. 1), 79-85.
45. La Via, M. C., Gray, H., & Kaye, W H. (2000). Case reports of olanzapine treatment of anorexia nervosa. International Journal of Eating Disorders, 27, 363-366.
46. Leitenberg, H., Rosen, J. C., Wolf, J., Vara, L. S., Detzer, M. J., & Srebnik, D. (1994). Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Behavior Research and Therapy, 32, 37-45.
47. Malina, A., Gaskill, J., McConaha, C., Frank, G. K., LaVia, M., Scholar, L., et al. (2003). Olanzapine treatment of anorexia nervosa: A retrospective study. International Journal of Eating Disorders, 33, 234-237.
48. McDermott, C., Agras, W. S., Crow, S. J., Halmi, K., Mitchell, J. E., & Bryson, S. (2004). Participant recruitment for an anorexia nervosa treatment study. International Journal of Eating Disorders, 35, 33-41.
49. McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, P. E., Rosenthal, N. R., Kari, M. R., et al. (2003). Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. American Journal of Psychiatry, 160, 255-261.
50. McElroy, S. L., Casuto, L. S., Nelson, E. B., Lake, K. A., Soutullo, C. A., Keck, P. E., et al. (2000). Placebo-controlled trial of sertraline in the treatment of binge eating disorder. American Journal of Eating Disorders, 157, 1004-1006.
51. Mehler, C., Wewetzer, C., Schulze, U., Warnke, A., Theisen, F., & Dittmann, R. W. (2001). Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases. European Child Adolescent Psychiatry, 10, 151-157.
52. Mitchell, J. E., de Zwaan, M., & Roerig, J. L. (2003). Drug therapy for patients with eating disorders. Current Drug Target CNS Neurological Disorders, 2, 17-29.
53. Mitchell, J. E., Halmi, K., Wilson, G. T., Agras, W. S., Kraemer, H., & Crow, S. (2002). A randomized secondary treatment study of women with bulimia nervosa who fail to respond to CBT. International Journal of Eating Disorders, 32, 271-281.
54. Mitchell, J. E., Peterson, C. B., Myers, T., & Wonderlich, S. (2001). Combining pharmacotherapy and psychotherapy in the treatment of patients with eating disorders. Psychiatric Clinics of North America, 24, 315-323.
55. Mitchell, J. E., Pyle, R. L., Eckert, E. D., Hatuskami, D., Pomery, C., & Zimmerman, R. (1990). A comparison study of antidepressants and structure intensive group psychotherapy in the treatment of bulimia nervosa. Archives of General Psychiatry, 47, 149-157.
56. Moore, D. C. (1977) Amitriptyline therapy in anorexia nervosa. American Journal of Psychiatry, 134, 1030-1034.
57. Needleman, H. L., & Waber, D. (1977). The use of amitriptyline inpatients with anorexia nervosa. In R. A. Vigersky (Ed.), Anorexia nervosa (pp. 357-362). New York: Raven Press.
58. Peterson, C. B., & Mitchell, J. E. (1999). Psychosocial and pharmacological treatment of eating disorders: A review of research findings. Journal of Clinical Psychology, 55, 685-697.
59. Peterson, C. B., Mitchell, J. E., Engbloom, S., Nugent, S., Pederson Mussell, M., Crow, S. J., et al. (2001). Self-help versus therapist-led group cognitive-behavioral treatment of binge eating disorder at follow-up. International Journal of Eating Disorders, 30, 363-374.
60. Pike, K. M. (2000, May). How do we keep patients well? Issues of relapse prevention. Paper presented at the 9th International Conference on Eating Disorders, New York City.
61. Pike, K. M., Walsh, B. T., Vitousek, K., Wilson, G. T., & Bauer, J. (2003). Cognitive behavior therapy in the post-hospitalization of treatment of anorexia nervosa. American Journal of Psychiatry, 160, 2046-2049.
62. Powers, P. S., Santana, C. A., & Bannon, Y. S. (2002). Olanzapine in the treatment of anorexia nervosa: An open label trial. International Journal of Eating Disorders, 32, 146-154.
63. Ricca, V., Mannucci, E., Mezzani, B., Di Bernardo, Barciulli, E., Moretti, S., et al. (1997). Cognitive-behavioral therapy versus combined treatment with group psychoeducation and fluoxetine in bulimic outpatients. Eating and Weight Disorders, 2, 94-99.
64. Ricca, V., Mannucci, E., Mezzani, B., Moretti, S., Di Bernardo, M., Bertelli, M., et al. (2001). Fluoxetine and fluvoxamine combined with individual cognitive-behavior therapy in binge eating disorder: A one year follow-up study. Psychosomatics and Psychotherapy, 70, 298-306.
65. Riva, G., Bacchetta, M., Cesa, G., Conti, S., & Molinari, E. (2003). Six-month follow-up of in-patient experiential cognitive therapy for binge eating disorders. Cyberpsychological Behavior, 6, 251-258.
66. Romano, S., Halmi, K., Sarkar, N., Koke, S., & Lee, J. (2002). A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. American Journal of Psychiatry, 159, 96-102.
67. Shapira, N. A., Goldsmith, T. D., & McElroy, S. L. (2000). Treatment of binge-eating disorder with topiramate: A clinical case series. Journal of Clinical Psychiatry, 61, 368-372.
68. Smith, D. E., Marcus, M. D., & Kaye, W. (1992). Cognitive behavioral treatment of obese binge eaters. International Journal of Eating Disorders, 12, 257-262.
69. Steinglass, J. E., & Walsh, B. T. (2004). Psychopharmacology of anorexia nervosa, bulimia nervosa, and binge eating disorder. In T. B Brewerton (Ed.), Clinical handbook of eating disorders (pp. 489-508). New York: Marcel Deeker.
70. Strober, M., & Katz, J. L. (1988). Depression in the eating disorders: A review and analysis of descriptive, family and biological findings. In D. M. Garner & P. E. Garfinkel (Eds.), Diagnostic issues in anorexia nervosa and bulimia nervosa. New York: Brunner/Mazel.
71. Strober, M., Pataki, C., Freeman, R., & DeAntonio, M. (1999). No effect of adjunctive fluoxetine on eating behavior or weight phobia during the inpatient treatment of anorexia nervosa: An historical case-controlled study. Journal of Child and Adolescent Psychopharmacology, 9, 195-201.
72. Vandereycken, W. (1984). Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind, placebo-controlled study with sulpiride. British Journal of Psychiatry, 144, 288-292.
73. Vandereycken, W. (1987). The use of neuroleptics in the treatment of anorexia nervosa patients. In P. E. Garfinkel & D. M. Garner (Eds.), The role of drug treatment in eating disorders. New York: Brunner/Mazel.
74. Vandereycken, W., & Pierloot, R. (1982). Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled crossover study. Acta Psychiatrica Scandinavica, 66, 445-450.
75. Vaswani, M., & Karlra, H. (2004). Selective serotonin re-uptake inhibitors in anorexia nervosa. Expert Opinion on Investigational Drugs, 13, 349-357.
76. Vaswani, M., Linda, F. K., & Ramesh, S. (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Progress in Neuropsychopharmacological Biological Psychiatry, 27, 85-102.
77. Vitousek, K. B. (2002). Cognitive-behavioral therapy for anorexia nervosa. In C. G. Fairburn & K. D. Brownell (Eds.), Eating disorders and obesity (2nd ed., pp. 308-313). New York: Guilford.
78. Walsh, B. T., Agras, W. S., Devlin, M. J., Fairburn, C. J., Wilson, G. T., Kahn, C., et al. (2000). Fluoxetine for bulimia nervosa following poor response to psychotherapy. American Journal of Psychiatry, 157, 1332-1334.
79. Walsh, B. T., Hadigan, C. M., Devlin, M. J., Gladis, M., & Roose, S. (1991). Long-term outcome of antidepressant treatment for bulimia nervosa. American Journal of Psychiatry, 148, 1206-1212.
80. Walsh, B. T., Wilson, G. T., Loeb, K. L., Devlin, M. J., Pike, K. M., Roose, S. P., et al. (1997). Medication and psychotherapy in the treatment of bulimia nervosa. American Journal of Psychiatry, 154, 523-531.
81. White, J. H., & Schnaultz, N. L. (1977). Successful treatment of anorexia nervosa with imipramine. Disorders of the Nervous System, 38, 567-568.
82. Wilfley, D. E., Welch, R. R., Stein, R. I., Spurrell, E. B., Cohen, L. R., Saeles, B. E., et al. (2002). A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Archives of General Psychiatry, 59, 713-721.
83. Wilson, G. T., Fairburn, C. G., & Agras, W. S. (1997). Cognitive behavioral therapy for bulimia nervosa. In D. M. Garner & P. E. Garfinkel (Eds.), Handbook of treatment for eating disorders (2nd ed., pp. 67-93). New York: Guilford.
84. Wilson, G. T., Vitousek, K. M., & Loeb, K. L. (2000.) Stepped care treatment for eating disorders. Journal of Consulting and Clinical Psychology, 68, 564-572.
85. Wolff, G. E., & Clark, M. M. (2001). Changes in eating self-efficacy and body image following cognitive-behavioral group therapy for binge eating disorder: A clinical study. Eating Behavior, 2, 97-104.
86. Wonderlich, S. A., Mitchell, J. E., Swan-Kremier, L., Peterson, C. B., & Crow, S. J. (2004). An overview of cognitive-behavioral approaches to eating disorders. In T. B. Brewerton (Ed.), Clinical handbook of eating disorders (pp. 403-424). New York: Marcel Dekker.
87. Wright, J. H., Thase, M. E., Beck, A. T., & Ludgate, J. W. (1993). Cognitive therapy with inpatients: Developing a cognitive milieu. New York: Guilford.
88. Yager, J. (2004). Future directions in the management of eating disorders. In T. B. Brewerton (Ed.), Clinical handbook of eating disorders (pp. 547-567). New York: Marcel Dekker.